New shot could shrink nasal polyps and ease breathing
NCT ID NCT07313917
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called LP-003 for people with long-term sinus inflammation and nasal polyps (growths in the nose). The goal is to see if it can shrink polyps and reduce stuffiness. About 150 adults will receive either the drug or a placebo, and their progress will be tracked for 24 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tongren Hospital Affiliated to Capital Medical University
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection shrink nasal polyps and restore easy breathing?
- Could a Pre-Surgery drug boost nasal polyp treatment?
- New study tests tezepelumab for chronic sinusitis sufferers
- 88% of patients with asthma and nasal polyps achieve dual remission on dupilumab
- Scientists probe the root cause of smell loss in chronic sinusitis
- Could a simple mucus test transform nasal polyp treatment?